LONDON--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM ...
Usually, the health tech I see at CES is vaporware, but good news! Dexcom’s Stelo continuous glucose biosensor just got FDA clearance, making it the first ever to not require a prescription. Stelo is ...
DexCom’s fourth quarter results reflected ongoing momentum in both product innovation and international expansion. Management attributed the quarter’s performance to the broad rollout of the G7 15-day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results